The Pune-based Serum Institute of India (SII) is
producing Covishield - the Oxford/AstraZeneca s COVID-19 vaccine. Poonawalla should lodge a complaint giving details of threat and the phone number from where he got the call.
We will conduct an in-depth probe into it, Minister of State Home Shamburaje Desai told reporters.
Meanwhile, Maharashtra Congress president Nana Patole urged Poonawalla to return to India and assured that his party will take the responsibility of his security.
ALSO WATCH: People s lives are important and the vaccine production should take place in India only. The Centre has already given him Y category security. More (security) would be given if necessary, he said.
Representative Image The third and the largest phase of vaccination, under which beneficiaries in the 18-45 age group will be given jabs against coronavirus, will begin here on Monday. Around 90 lakh people in this category will be eligible for the jabs. Five vaccination booths each have been set up at 77 schools for the inoculation exercise, an official said on Sunday. The government set up vaccination centres at schools to accommodate a high number of beneficiaries, he said. At present, jabs are being given to those aged above 45 at around 500 centres in the national capital. Pre-registration will be mandatory for beneficiaries in the 18-45 age group and there will be no walk-ins for this category for now, the official said.
Goa unable to start vaccination for people above 18 due to lack of doses
SECTIONS
Last Updated: May 01, 2021, 05:54 PM IST
Share
Synopsis People should not rush to health centres as the vaccination for those in the age group of 18 to 45 years is yet to start. It will begin once we procure vaccine doses, Chief Minister Pramod Sawant told reporters.
Agencies
Chief Minister Pramod Sawant said the state has placed an order for doses with the Pune-based Serum Institute of India.
The Goa government could not start the drive to inoculate the 18 to 45 age group in the state on Saturday due to unavailability of vaccine doses. Chief Minister Pramod Sawant said the state has placed an order for doses with the Pune-based Serum Institute of India.
Sri Lanka looking at sources other than India to buy AstraZeneca COVID-19 vaccine
Gen Shavendra Silva, chief of COVID prevention operations, said supply is being delayed from the Serum Institute of India in the wake of the current COVID crisis in the country
PTI | May 1, 2021 | Updated 16:02 IST
Sri Lanka is looking at sources other than India to purchase the Oxford/AstraZeneca vaccine in view of delay in securing the vaccines from the Serum Institute of India, health authorities said on Saturday. The supply is being delayed from India. We have to understand that India has to look after their own country before supplying to us. It is not that they have told no to us, Gen Shavendra Silva, the chief of the COVID prevention operations told reporters.
Serum Institute CEO Adar Poonawalla plans vaccine production outside India: Report
Twitter/ @adarpoonawalla
With the surge in coronavirus cases and deaths in India, Pune-based Serum Institute of India (SII) is struggling to meet supplies. CEO Adar Poonawalla told Times of India on Friday that the firm is planning to begin vaccine production outside India. Poonawalla said, âthere s going to be an announcement in the next few daysâ.
The SII, which is India s largest vaccine manufacturer and the worldâs by volume, manufactures the AstraZeneca COVID-19 vaccine jointly developed with Oxford University. It is sold in India under the name Covishield.